Delivery Order SPE2DB20D2014-SPE2DB23FD38V
Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,667.95 firm fixed price delivery order is for the pharmaceutical product XIFAXAN 550 mg tablet. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to...
- This federal contract award, valued at $8,914.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- The Defense Logistics Agency (DLA) awarded a $6,791.24 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of XIFAXAN 550 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, to deliver a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,777.98 for the supply of the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of June 21, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,106.51, is a delivery order for the drug XIFAXAN 550 MG TABLET 60S. The contract has a firm fixed price and an ultimate completion date of September 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,827.01 and a performance period ending on July 15, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a $6,949.97 firm fixed price Delivery Order, with a completion date of September 20, 2024. It is not designated as a set-aside contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XIFAXAN 550 mg tablets. The $4,514.80 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on April 23, 2024 with a completion date of April 24, 2024. The contract has no set-aside designation. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of...
- This federal contract award to AmerisourceBergen Drug Corp., a subsidiary of Cencora, Inc., is a delivery order valued at $48,893.33 to provide the pharmaceutical product XIFAXAN 550 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of May 7, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $32,717.77, was issued by the Medical Supply Chain division of the U.S. Department of Defense (DoD) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award is for the provision of the prescription medication Xifaxan 550 mg tablets. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....